Skip to main content
SpringerLink
Log in

Combined treatment of anaplastic astrocytoma (grade 3–4) with diacetyl-dianhydro-galactitol (DADAG)

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Autoradiographic studies of labeled diacetyldianhydro-galactitol (DADAG) with tumor bearing animals revealed that the CNS accumulates high amounts of DADAG-derived radioactivity and the elimination from the brain seems to be relatively slow. This observation and the activity of DADAG against murine ependymoblastoma classified the drug as a promising agent for the treatment of malignant brain tumors.

In a series of 30 evaluable consecutive patients who were operated on for anaplastic astrocytomas, DADAG has been applied during and subsequent to postoperative radiotherapy. No severe toxicity occurred. Survivals were compared with a group of patients who got irradiation alone. Statistical analysis did not show significantly better survivals in the DADAG treated group: median value was 46.5 weeks, p = 0.232.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chiuten DF, Rozencweig M, Von Hoff DD, Muggia FM: Clinical trials with the hexitol derivatives in the U.S. Cancer 47: 442–451, 1981

    Google Scholar 

  2. Eckhardt S (ed) Dibromodulcitol. Medicina Könyvkiadó, Budapest 1982

    Google Scholar 

  3. Kornblith PL, Walker MD: Chemotherapy for malignant gliomas. Review Article. J Neurosurg 68: 1–17, 1988

    Google Scholar 

  4. Afra D, Kocsis B, Dobay J, Eckhardt S: Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 59: 106–110, 1983

    Google Scholar 

  5. Somfai-Relle S, Gáti E, Bencze J, Gál F: New derivatives of dianhydrogalactitol (NSC-132313) with significant antitumour activity. In: Siegenthaler W, Lüthy R (eds) Current chemotherapy, vol. II. American Society of Microbiologist, Washington, p 1302, 1978

    Google Scholar 

  6. Kerpel-Fronius S, Erdélyi-Tóth V, Gyergyay F, Hindy I, Mechl Z, Nekulová M, Somfai-Relle S, Kovács P, Ujj Gy, Kanyär B, Eckhardt S: Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydro-galactitol (DADAG). Cancer Chemother Pharmacol 16: 264–268, 1986

    Google Scholar 

  7. Erdélyi-Tóth V, Kerpel-Fronius S, Kanyár B, Eckhardt S: Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG). Cancer Chemother Pharmacol 16: 257–263, 1986

    Google Scholar 

  8. Ullberg S: The technique of whole body autoradiography. Cryosectioning of large specimen. Science tools, Special issue: 2–29, 1977

  9. Zülch KJ: International histological classification of tumours No 21, In: Histological Typing of Tumours of the central nervous system. Geneva: World Health Organization, 1979

    Google Scholar 

  10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958

    Google Scholar 

  11. Cox DR: Regression models and life tables. JR Stat Soc (B) 34: 187–202, 1972

    Google Scholar 

  12. Walker MD, Alexander Jr B, Hunt WE, MacCarty CS, Mahaley Jr MS, Mealey Jr J, Norrel HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343, 1978

    Google Scholar 

  13. Green SB, Byar DP, Walker MD, Pistemaa DA, Alexander Jr E, Batzdorf U, Brooks WH, Hunt WE, Mealey Jr J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith Jr KR, Wilson CB, Strike TA: Comparisons of Carmustine, Procarbazine and high dose Methylprednisolon as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 121–132, 1983

    Google Scholar 

  14. EORTC Brain Tumour Group: Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: randomized double-blind study. Eur J Cancer Clin Oncol 19: 29–42, 1983

    Google Scholar 

  15. Eagan RT, Childs Jr DD, Layton Jr DD, Laws Jr ER, Bisel HF, Holbrook MA, Fleming TR: Dianhydrogalactitol and radiation therapy. JAMA 241: 2046–2050, 1979

    Google Scholar 

  16. Levin VA, Vestnys PS, Edwards MS, Wara WW, Fulton D, Barger G, Seager M, Wilson CB: Improvement in survival by sequential therapies in the treatment of recurrent medulloblastoma. Cancer 51: 1364–1370, 1983

    Google Scholar 

  17. Espana P, Wiernik PH, Walker MD: Phase II study of dianhydrogalactitol in malignant glioma. Cancer Treat Rep 62: 1199#x2013;1200

Download references

Author information

Authors and Affiliations

  1. National Institute of Neurosurgery, H-1145, Budapest, Amerikai fit 57, Hungary

    Dénes Áfra, Sändor Kerpel-Fronius, István Szinai, Béla Kocsis & Sändor Eckhardt

  2. National Institute of Oncology, Budapest

    Dénes Áfra, Sändor Kerpel-Fronius, István Szinai, Béla Kocsis & Sändor Eckhardt

  3. Central Research Institute for Chemistry of the Hungarian Academy of Sciences, Budapest, Hungary

    Dénes Áfra, Sändor Kerpel-Fronius, István Szinai, Béla Kocsis & Sändor Eckhardt

Authors
  1. Dénes Áfra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sändor Kerpel-Fronius
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. István Szinai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Béla Kocsis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sändor Eckhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Áfra, D., Kerpel-Fronius, S., Szinai, I. et al. Combined treatment of anaplastic astrocytoma (grade 3–4) with diacetyl-dianhydro-galactitol (DADAG). J Neuro-Oncol 8, 85–91 (1990). https://doi.org/10.1007/BF00182091

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00182091

Key words

Search

Navigation